Shukra Pharmaceuticals Limited (BOM:524632)
40.78
-0.65 (-1.57%)
At close: Mar 9, 2026
Shukra Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 17,857 | 9,568 | 3,575 | 514 | 95 | 70 | Upgrade
|
| Market Cap Growth | 97.34% | 167.65% | 595.01% | 443.89% | 35.73% | -4.81% | Upgrade
|
| Enterprise Value | 17,761 | 9,415 | 3,504 | 520 | 199 | 165 | Upgrade
|
| Last Close Price | 40.78 | 21.84 | 8.03 | 1.15 | 0.31 | 0.23 | Upgrade
|
| PE Ratio | 102.84 | 99.92 | 19.28 | 11.67 | 12.60 | 37.04 | Upgrade
|
| PS Ratio | 27.66 | 29.36 | 4.79 | 0.87 | 0.46 | 0.62 | Upgrade
|
| PB Ratio | 27.14 | 15.23 | 6.20 | 2.03 | 0.58 | 0.45 | Upgrade
|
| P/TBV Ratio | 27.14 | 15.23 | 6.20 | 2.03 | 0.58 | 0.45 | Upgrade
|
| P/FCF Ratio | - | 184.87 | - | - | 1.47 | - | Upgrade
|
| P/OCF Ratio | - | 120.83 | - | 16.23 | 1.18 | 12.97 | Upgrade
|
| EV/Sales Ratio | 27.51 | 28.89 | 4.70 | 0.88 | 0.97 | 1.47 | Upgrade
|
| EV/EBITDA Ratio | 45.17 | 60.91 | 16.18 | 8.01 | 6.78 | 9.38 | Upgrade
|
| EV/EBIT Ratio | 49.89 | 75.61 | 17.87 | 11.17 | 15.63 | 58.82 | Upgrade
|
| EV/FCF Ratio | - | 181.91 | - | - | 3.09 | - | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.07 | 0.06 | 0.20 | 0.21 | 0.63 | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | 0.27 | 0.15 | 0.78 | 1.15 | 5.57 | Upgrade
|
| Debt / FCF Ratio | - | 0.81 | - | - | 0.52 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.15 | -0.13 | -0.12 | 0.04 | 0.19 | 0.59 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.24 | -0.51 | -0.31 | 0.17 | 1.05 | 5.29 | Upgrade
|
| Net Debt / FCF Ratio | - | -1.53 | 0.98 | -0.84 | 0.48 | -7.39 | Upgrade
|
| Asset Turnover | - | 0.40 | 0.98 | 1.08 | 0.58 | 0.32 | Upgrade
|
| Inventory Turnover | - | 1.35 | 16.28 | 12.78 | 3.73 | 1.81 | Upgrade
|
| Quick Ratio | - | 2.33 | 2.89 | 1.00 | 0.62 | 1.46 | Upgrade
|
| Current Ratio | - | 3.79 | 3.97 | 1.25 | 1.28 | 2.28 | Upgrade
|
| Return on Equity (ROE) | - | 15.90% | 44.70% | 21.16% | 4.70% | 1.21% | Upgrade
|
| Return on Assets (ROA) | - | 9.46% | 16.04% | 5.29% | 2.25% | 0.51% | Upgrade
|
| Return on Invested Capital (ROIC) | 51.34% | 16.91% | 47.35% | 20.16% | 4.24% | 1.16% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 17.90% | 30.80% | 14.40% | 5.60% | 1.00% | Upgrade
|
| Earnings Yield | 1.63% | 1.00% | 5.19% | 8.57% | 7.94% | 2.70% | Upgrade
|
| FCF Yield | - | 0.54% | -1.95% | -2.57% | 68.08% | -18.00% | Upgrade
|
| Dividend Yield | 0.02% | 0.05% | 1.24% | 1.09% | 4.06% | - | Upgrade
|
| Payout Ratio | - | 45.73% | 0.38% | 1.65% | - | - | Upgrade
|
| Buyback Yield / Dilution | -68.39% | - | -551.03% | -7.38% | - | -0.02% | Upgrade
|
| Total Shareholder Return | -68.36% | 0.05% | -549.78% | -6.29% | 4.06% | -0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.